BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

948 related articles for article (PubMed ID: 16143574)

  • 1. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
    Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
    Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor.
    Nakajima F; Ogasawara A; Goto K; Moriya H; Ninomiya Y; Einhorn TA; Yamazaki M
    J Orthop Res; 2001 Sep; 19(5):935-44. PubMed ID: 11562144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).
    Nakajima A; Shimoji N; Shiomi K; Shimizu S; Moriya H; Einhorn TA; Yamazaki M
    J Bone Miner Res; 2002 Nov; 17(11):2038-47. PubMed ID: 12412812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures.
    Kakar S; Einhorn TA; Vora S; Miara LJ; Hon G; Wigner NA; Toben D; Jacobsen KA; Al-Sebaei MO; Song M; Trackman PC; Morgan EF; Gerstenfeld LC; Barnes GL
    J Bone Miner Res; 2007 Dec; 22(12):1903-12. PubMed ID: 17680724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax deficiency in mice increases cartilage production during fracture repair through a mechanism involving increased chondrocyte proliferation without changes in apoptosis.
    Rundle CH; Wang X; Sheng MH; Wergedal JE; Lau KH; Mohan S
    Bone; 2008 Nov; 43(5):880-8. PubMed ID: 18708175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase.
    Andreassen TT; Willick GE; Morley P; Whitfield JF
    Calcif Tissue Int; 2004 Apr; 74(4):351-6. PubMed ID: 15255072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intermittent low-dose administration of recombinant human parathyroid hormone (1-34) promotes the expression of Runx2 during early stage of fracture healing].
    Li N; Wang MY; He L; Jiang X; Wu CA
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):771-6. PubMed ID: 19595108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.
    Rowshan HH; Parham MA; Baur DA; McEntee RD; Cauley E; Carriere DT; Wood JC; Demsar WJ; Pizarro JM
    J Oral Maxillofac Surg; 2010 Feb; 68(2):260-7. PubMed ID: 20116693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of parathyroid hormone-related peptide and insulin-like growth factor I during rat fracture healing.
    Okazaki K; Jingushi S; Ikenoue T; Urabe K; Sakai H; Iwamoto Y
    J Orthop Res; 2003 May; 21(3):511-20. PubMed ID: 12706025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.
    Andreassen TT; Fledelius C; Ejersted C; Oxlund H
    Acta Orthop Scand; 2001 Jun; 72(3):304-7. PubMed ID: 11480610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model.
    Huh JE; Kwon NH; Baek YH; Lee JD; Choi DY; Jingushi S; Kim KI; Park DS
    Int Immunopharmacol; 2009 Nov; 9(12):1357-65. PubMed ID: 19695348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures.
    Andreassen TT; Ejersted C; Oxlund H
    J Bone Miner Res; 1999 Jun; 14(6):960-8. PubMed ID: 10352105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cartilage-derived retinoic acid-sensitive protein and type II collagen expression during fracture healing are potential targets for Sox9 regulation.
    Sakano S; Zhu Y; Sandell LJ
    J Bone Miner Res; 1999 Nov; 14(11):1891-901. PubMed ID: 10571689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a novel chondrocytic cell line N1511 derived from p53-null mice.
    Kamiya N; Jikko A; Kimata K; Damsky C; Shimizu K; Watanabe H
    J Bone Miner Res; 2002 Oct; 17(10):1832-42. PubMed ID: 12369787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.
    Chang JK; Chang LH; Hung SH; Wu SC; Lee HY; Lin YS; Chen CH; Fu YC; Wang GJ; Ho ML
    Arthritis Rheum; 2009 Oct; 60(10):3049-60. PubMed ID: 19790062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
    Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
    Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
    Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
    J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48.
    Rozen N; Lewinson D; Bick T; Jacob ZC; Stein H; Soudry M
    Bone; 2007 Sep; 41(3):437-45. PubMed ID: 17599848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation.
    Hashimoto T; Shigetomi M; Ohno T; Matsunaga T; Muramatsu K; Tanaka H; Sugiyama T; Taguchi T
    Calcif Tissue Int; 2007 Sep; 81(3):232-9. PubMed ID: 17674071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local anabolic effects of growth hormone on intact bone and healing fractures in rats.
    Andreassen TT; Oxlund H
    Calcif Tissue Int; 2003 Sep; 73(3):258-64. PubMed ID: 14667139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.